Other Investments	3 Months Ended
Mar. 31, 2026
Investments, All Other Investments [Abstract]
Other Investments	Other Investments In prior years the Company made minority ownership strategic investments. As of both March 31, 2026 and December 31, 2025, the aggregate carrying amount of the Company’s strategic investments in non-publicly traded companies was $19.0 million. These investments are measured at initial cost, minus impairment, if any, and plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Cumulative impairments of strategic investments in equity investments without readily determinable fair values still held as of both March 31, 2026 and December 31, 2025 were $23.0 million, reflecting the full impairment of two of the Company’s other investments. As a part of the acquisition of each of the Company’s other investments, the Company determines whether an investment or other interest is considered a variable interest. As of both March 31, 2026 and December 31, 2025, the Company held an interest in one entity that was concluded to be a variable interest for which the Company was not the primary beneficiary as the Company did not have the power to direct the activities that most significantly impact the economic performance of the variable interest entity. As of both March 31, 2026 and December 31, 2025, the carrying value and maximum exposure to loss of the Company’s variable interests was zero.

In prior years the Company made minority ownership strategic investments. As of both March 31, 2026 and December 31, 2025, the aggregate carrying amount of the Company’s strategic investments in non-publicly traded companies was $19.0 million. These investments are measured at initial cost, minus impairment, if any, and plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Cumulative impairments of strategic investments in equity investments without readily determinable fair values still held as of both March 31, 2026 and December 31, 2025 were $23.0 million, reflecting the full impairment of two of the Company’s other investments.

As a part of the acquisition of each of the Company’s other investments, the Company determines whether an investment or other interest is considered a variable interest. As of both March 31, 2026 and December 31, 2025, the Company held an interest in one entity that was concluded to be a variable interest for which the Company was not the primary beneficiary as the Company did not have the power to direct the activities that most significantly impact the economic performance of the variable interest entity. As of both March 31, 2026 and December 31, 2025, the carrying value and maximum exposure to loss of the Company’s variable interests was zero.